These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice. Akita Y, Kuroshima S, Nakajima K, Hayano H, Kanai R, Sasaki M, Sawase T. J Bone Miner Metab; 2018 Sep; 36(5):547-559. PubMed ID: 29043461 [Abstract] [Full Text] [Related]
3. Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice. Hayano H, Kuroshima S, Sasaki M, Tamaki S, Inoue M, Ishisaki A, Sawase T. Bone; 2020 Jun; 135():115308. PubMed ID: 32142911 [Abstract] [Full Text] [Related]
4. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. de Molon RS, Shimamoto H, Bezouglaia O, Pirih FQ, Dry SM, Kostenuik P, Boyce RW, Dwyer D, Aghaloo TL, Tetradis S. J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550 [Abstract] [Full Text] [Related]
5. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice. Kuroshima S, Sasaki M, Nakajima K, Tamaki S, Hayano H, Sawase T. Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428 [Abstract] [Full Text] [Related]
6. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. de Molon RS, Cheong S, Bezouglaia O, Dry SM, Pirih F, Cirelli JA, Aghaloo TL, Tetradis S. Bone; 2014 Nov; 68():11-9. PubMed ID: 25093262 [Abstract] [Full Text] [Related]
8. Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect. Lim SS, Lee B, Kim IS, Hwang SJ. Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jan; 123(1):8-19. PubMed ID: 27727104 [Abstract] [Full Text] [Related]
9. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease. Soundia A, Hadaya D, Esfandi N, de Molon RS, Bezouglaia O, Dry SM, Pirih FQ, Aghaloo T, Tetradis S. Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410 [Abstract] [Full Text] [Related]
10. Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel. Miyazaki H, Nishimatsu H, Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Ishikawa A, Igawa Y, Hirano Y, Homma Y. BJU Int; 2012 Dec; 110(11 Pt B):E520-5. PubMed ID: 22578070 [Abstract] [Full Text] [Related]
11. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model. Ersan N, van Ruijven LJ, Bronckers AL, Olgaç V, Ilgüy D, Everts V. Dentomaxillofac Radiol; 2014 Dec; 43(1):20130144. PubMed ID: 24170800 [Abstract] [Full Text] [Related]
12. Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study. de Molon RS, Hsu C, Bezouglaia O, Dry SM, Pirih FQ, Soundia A, Cunha FQ, Cirelli JA, Aghaloo TL, Tetradis S. J Bone Miner Res; 2016 Aug; 31(8):1596-607. PubMed ID: 26950411 [Abstract] [Full Text] [Related]
13. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S. J Bone Miner Res; 2013 Jul; 28(7):1631-40. PubMed ID: 23426919 [Abstract] [Full Text] [Related]
14. Transplantation of Noncultured Stromal Vascular Fraction Cells of Adipose Tissue Ameliorates Osteonecrosis of the Jaw-Like Lesions in Mice. Kuroshima S, Sasaki M, Nakajima K, Tamaki S, Hayano H, Sawase T. J Bone Miner Res; 2018 Jan; 33(1):154-166. PubMed ID: 28902422 [Abstract] [Full Text] [Related]
15. Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma. Smidt-Hansen T, Folkmar TB, Fode K, Agerbaek M, Donskov F. J Oral Maxillofac Surg; 2013 Sep; 71(9):1532-40. PubMed ID: 23642545 [Abstract] [Full Text] [Related]
16. Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients. Lescaille G, Coudert AE, Baaroun V, Ostertag A, Charpentier E, Javelot MJ, Tolédo R, Goudot P, Azérad J, Berdal A, Spano JP, Ruhin B, Descroix V. Bone; 2014 Jan; 58():103-7. PubMed ID: 24120382 [Abstract] [Full Text] [Related]
17. Lansoprazole and zoledronate delays hard tissue healing of tooth extraction sockets in dexamethasone-treated mice. Yoshioka R, Mine Y, Kaku M, Nikawa H, Murayama T. Biomed Pharmacother; 2022 Jun; 150():112991. PubMed ID: 35462336 [Abstract] [Full Text] [Related]
18. Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment? Pilanci KN, Alco G, Ordu C, Sarsenov D, Celebi F, Erdogan Z, Agacayak F, Ilgun S, Tecimer C, Demir G, Eralp Y, Okkan S, Ozmen V. Medicine (Baltimore); 2015 May; 94(18):e671. PubMed ID: 25950681 [Abstract] [Full Text] [Related]
19. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease. Kim JW, Tatad JCI, Landayan MEA, Kim SJ, Kim MR. Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440 [Abstract] [Full Text] [Related]
20. Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing. Kuroshima S, Entezami P, McCauley LK, Yamashita J. Osteoporos Int; 2014 Mar; 25(3):1141-50. PubMed ID: 24301537 [Abstract] [Full Text] [Related] Page: [Next] [New Search]